Latest liver cancer Stories
Ethics Boards at Three Hospitals in Germany Approve Trial Expansion NEW YORK, May 21, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Led by Georgia State University, researchers have developed the first robust and noninvasive detection of early stage liver cancer and liver metastases, in addition to other liver diseases, such
First patient dosed in Europe PETACH TIKVA, Israel, May 11, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd.
- Company on track to file IND and initiate Phase 1 clinical trial in mid-2015 - CAMBRIDGE, Mass., April 24, 2015 /PRNewswire/ -- Blueprint Medicines today announced new preclinical data demonstrating
PHOENIX, April 22, 2015 /PRNewswire/ --
NEW YORK, April 21, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Designation would provide study protocol assistance and market exclusivity PETACH TIKVA, Israel, April 20, 2015 /PRNewswire/ -- Can-Fite
--Phase 3 Trial to Begin Enrolling Patients Later This Year-- SAN FRANCISCO, April 16, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage biotherapeutics company focused
According to the new report from BCC Research, the global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014.
Researchers at UC Davis have unraveled some of these relationships, identifying several interactions that directly impact liver and colon cancer. SACRAMENTO,
- A woman chauffeur.
- A woman who operates an automobile.